Epidemiology of non-alcoholic fatty liver disease in China

Journal of Hepatology

Volumn 50, Issue 1, 2009, Pages 204-210

  Fan, Jian Gao ^a,b   Farrell, Geoffrey C ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b The Australian National University   (Australia)

Author keywords

Chinese; Hepatitis B; Hepatitis C; Metabolic syndrome; Non alcoholic fatty liver disease; Obesity

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ALCOHOLISM; CARDIOVASCULAR DISEASE; CHINA; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

CHINA; FATTY LIVER; HUMANS; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTORS;

EID: 56949097660     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.10.010     Document Type: Review

References (66)

1. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25 (2007) 883-889
2. Williams R. Global changes in liver disease. Hepatology 44 (2006) 521-526
3. Amarapurkar D.N., Hashimoto E., Lesmana L.A., Sollano J.D., Chen P.J., and Goh K.L. Asia-Pacific Working Party for NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?. J Gastroenterol Hepatol 22 (2007) 788-793
4. Wu Y. Overweight and obesity in China. The once lean giant has a weight problem that is increasing rapidly. BMJ 19 (2006) 362-363
5. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
6. Fan J.G., Saibara T., Chitturi S., Kim B.I., Sung J.J., and Chutaputti A. Asia-Pacific Working Party for NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?. J Gastroenterol Hepatol 22 (2007) 794-800
7. Liu J., and Fan D. Hepatitis B in China. Lancet 369 (2007) 1582-1583
8. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
9. Yajima Y., Ohta K., Narui T., Abe R., Suzuki H., and Ohtsuki M. Ultrasonographic diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 139 (1983) 43-50
10. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2003;11:71.
11. Zeng M.D., Fan J.G., Lu L.G., Li Y.M., Chen C.W., Wang B.Y., et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease. J Dig Dis 9 (2008) 108-112
12. Farrell G.C., Chitturi S., Lau G.K., and Sollano J.D. Asia-Pacific Working Party for NAFLD Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22 (2007) 775-777
13. Liew P.L., Lee W.J., Lee Y.C., Wang H.H., Wang W., and Lin Y.C. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes Surg 16 (2006) 1584-1593
14. Fan J.G. Steatohepatitis studies in China. Shijie Huaren Xiaohua Zazhi 9 (2001) 6-10
15. Zhang H.J., Zhuang H., and Liu X.E. Advances in the epidemiological study of fatty liver. Zhonghua Liu Xing Bing Xue Za Zhi 25 (2004) 630-632
16. Fan J.G., and Peng Y.D. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 6 (2007) 572-578
17. Deurenberg P., Deurenberg-Yap M., and Guricci S. Aisians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev 3 (2002) 141-146
18. Fan J.G., Zhu J., Li X.J., Chen L., Li L., Dai F., et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 43 (2005) 508-514
19. Zhou Y.J., Li Y.Y., Nie Y.Q., Ma J.X., Lu L.G., Shi S.L., et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 13 (2007) 6419-6424
20. Li Y.M. Alcoholism and alcoholic liver disease: focusing on epidemiological investigation in Asia. Hepatobiliary Pancreat Dis Int 4 (2005) 170-172
21. Yiu D.C., and Leung N.W. Epidemiological study: nonalcoholic fatty liver disease in Hong Kong Chinese. Hepatology 40 (2004) 582A
22. Chen C.H., Huang M.H., Yang J.C., Nien C.K., Yang C.C., Yeh Y.H., et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 40 (2006) 745-752
23. Fan J.G., Li F., Cai X.B., Peng Y.D., Ao Q.H., and Gao Y. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol 22 (2007) 663-668
24. Wang Z., Xia B., Ma C., Hu Z., Chen X., and Cao P. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. Postgrad Med J 83 (2007) 192-195
25. Chen C.H., Huang M.H., Yang J.C., Nien C.K., Yang C.C., Yeh Y.H., et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 22 (2007) 1482-1489
26. Fan J.G., Zeng M.D., and Li J.Q. Analysis of risk factors for fatty liver. Zhonghua Yifengyixue Zazhi 32 (1998) 189
27. Zhou J., Jia W.P., Bao Y.Q., Ma X.J., Lu W., Yu M., et al. Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi 87 (2007) 2249-2252
28. Hu Z.W., Guo J.W., and Deng X.L. Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease. Nan Fang Yi Ke Da Xue Xue Bao 26 (2006) 853-855
29. Huang H.L., Lin W.Y., Lee L.T., Wang H.H., Lee W.J., and Huang K.C. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg 17 (2007) 1457-1463
30. Fan J.G., Zhu J., Li X.J., Chen L., Lu Y.S., Li L., et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 20 (2005) 1825-1832
31. Wong V.W., Hui A.Y., Tsang S.W., Chan J.L., Tse A.M., Chan K.F., et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 4 (2006) 1154-1161
32. Hui J.M., Hodge A., Farrell G.C., Kench J.G., Kriketos A., and George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology 40 (2004) 46-54
33. Wong V.W., Hui A.Y., Tsang S.W., Chan J.L., Wong G.L., Chan A.W., et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 24 (2006) 1215-1222
34. Angulo P., Hui J.M., Marchesini G., Bugianesi E., George J., Farrell G.C., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45 (2007) 846-854
35. Fan J.G., and Farrell G.C. VAT fat is bad for the liver, SAT fat is not!. J Gastroenterol Hepatol 23 (2008) 829-832
36. Liu K.H., Chan Y.L., Chan J.C., Chan W.B., and Kong W.L. Mesenteric fat thickness as an independent determinant of fatty liver. Int J Obes (Lond) 30 (2006) 787-793
37. Vega G.L., Chandalia M., Szczepaniak L.S., and Grundy S.M. Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology 46 (2007) 716-722
38. Fan J.G., Zeng M.D., and Wang L.G. Clinical epidemiology on relationship of fatty liver with viral hepatitis. Shanghai Yixue 24 (2001) 119-120
39. Hui Y., Yu-yuan L., Yu-qiang N., Wei-Hong S., Yan-Lei D., Xiao-Bo L., et al. Effect of peroxisome proliferator-activated receptors-γ and co-activator-1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int 28 (2008) 385-392
40. Wong V.W.S., Wong G.L.H., Tsang S.W.C., Hui A.Y., Chan A.W., Choi P.C., et al. Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese. J Gastroenterol Hepatol 23 (2008) 914-921
41. Fueki Y., Miida T., Wardaningsih E., Ito M., Nakamura A., Takahashi A., et al. Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity. Clin Chim Acta 382 (2007) 71-76
42. Freiberg M.S., Cabral H.J., Heeren T.C., Vasan R.S., and Curtis Ellison R. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 27 (2004) 2954-2959
43. Fan J.G., Cai X.B., Li L., Li X.J., Dai F., and Zhu J. A population-based study of alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation. World J Gastroenterol 14 (2008) 2418-2424
44. Fung K.T., Fung J., Lai C.L., and Yuen M.F. Etiologies of chronic liver diseases in Hong Kong. Eur J Gastroenterol Hepatol 19 (2007) 659-664
45. Lang Z.W., Hu Z.J., Wang S.K., Zhang L.J., Meng X., and Song C.Z. A clinicopathological study on nonalcoholic steatohepatitis. Zhonghua Gan Zang Bing Za Zhi 11 (2003) 81-83
46. George J., and Farrell G.C. Practical approach to the diagnosis and management of people with fatty liver diseases. In: Farrell G.C., George J., de la M Hall P., and McCullough A.J. (Eds). Fatty liver disease: NASH and related disorders (2005), Blackwell Publishing, Malden, MA 181-193
47. Hui A.Y., Wong V.W., Chan H.L., Liew C.T., Chan J.L., Chan K.F., et al. Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment Pharmacol Ther 21 (2005) 407-413
48. Zheng R.D., Lu L.G., Meng J.R., Huang J.D., Rao R.C., Xu C.R., et al. A clinical and pathological study of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 14 (2006) 449-452
49. Jin H.B., Gu Z.Y., Yu C.H., and Li Y.M. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients. Hepatobiliary Pancreat Dis Int 4 (2005) 389-392
50. Pan H.Y., Ye R.X., Shi J.P., and Guo X.F. Pathological and clinical analysis of nonalcoholic steatohepatitis. Zhonghua Gan Zang Bing Za Zhi 11 (2003) 384
51. Tang C.P., Huang Y.S., Tsay S.H., Chang F.Y., and Lee S.D. Nonalcoholic fatty liver disease manifesting esophageal variceal bleeding. J Chin Med Assoc 69 (2006) 175-178
52. Farrell G.C. Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressing. J Gastroenterol Hepatol 23 (2008) 508-511
53. Qian Y., and Fan J.G. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int 4 (2005) 173-177
54. Fan J.G., Li F., Cai X.B., Peng Y.D., Ao Q.H., and Gao Y. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 22 (2007) 1086-1091
55. Chitturi S., and Farrell G.C. Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health. J Gastroenterol Hepatol 22 (2007) 967-969
56. Fan J.G. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. J Dig Dis 9 (2008) 63-67
57. Bjornsson E., and Angulo P. Hepatitis C and steatosis. Arch Med Res 38 (2007) 621-627
58. Fan J.G., and Chitturi S. Hepatitis B and fatty liver: causal or coincidental?. J Gastroenterol Hepatol 23 (2008) 679-681
59. Jian-Wu Y., Shu-Chen L., and Gui-Qiang W. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C. Liver Int 26 (2006) 166-172
60. Hsing A.W., Zhang M., Rashid A., McGlynn K.A., Wang B.S., Niwa S., et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 122 (2008) 1849-1853
61. Leung N., Chu C., and Tam J.S. Viral hepatitis C in Hong Kong. Intervirology 49 (2006) 23-27
62. Shi J.P., Fan J.G., Wu R., Gao X.Q., Zhang L., Wang H., et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B. J Hepatol 48 (2008) S342-S343
63. Shi J.P., Fan J.G., Wu R., Gao X.Q., Zhang L., Wang H., et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 23 (2008) 1419-1425
64. Shen L., Fan J.G., Shao Y., Zeng M.D., Wang J.R., Luo G.H., et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 9 (2003) 1106-1110
65. Luo B., Wang Y., and Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta 380 (2007) 238-240
66. Jan C.F., Chen C.J., Chiu Y.H., Chen L.S., Wu H.M., Huang C.C., et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond) 30 (2006) 794-799